United Therapeutics Company

United Therapeutics Corporation is an American publicly traded biotechnology companyt hat focuses on develop novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing.


Invests into

Funding Status: IPO
Headquarters: United States
Founded Date: 1996-01-01
Investor Type: N/A
Investment Stage: N/A
Technology: COVID-19 Investors
Employee Number: 501-1000
Number Of Exists: N/A
Estimated Revenue: $100M to $500M
Industry: Altered Signaling